This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
Bennett, Charles
| Item Type | Name |
|
Concept
|
Clinical Trials, Phase III as Topic
|
|
Concept
|
Clinical Trials, Phase II as Topic
|
|
Academic Article
|
Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia.
|
|
Academic Article
|
Hyponatremia and other toxic effects during a phase I trial of recombinant human gamma interferon and vinblastine.
|
|
Academic Article
|
Free-riding and the prisoner's dilemma: problems in funding economic analyses of phase III cancer clinical trials.
|
|
Academic Article
|
Granulocyte-macrophage colony-stimulating factor as adjunct therapy in relapsed lymphoid malignancy: implications for economic analyses of phase III clinical trials.
|
|
Academic Article
|
The effect of reimbursement policies on the management of Medicare patients with refractory ovarian cancer.
|
|
Academic Article
|
Economic analysis in phase III clinical cancer trials.
|
|
Academic Article
|
Economic analysis during phase III clinical trials: who, what, when, where, and why?
|
|
Academic Article
|
Economic analyses of phase III cooperative cancer group clinical trials: are they feasible?
|
|
Academic Article
|
Cost-effectiveness model of a phase II clinical trial of a new pharmaceutical for essential thrombocythemia: is it helpful to policy makers?
|
|
Academic Article
|
Gemtuzumab ozogamicin-associated sinusoidal obstructive syndrome (SOS): an overview from the research on adverse drug events and reports (RADAR) project.
|
|
Academic Article
|
Treatment success in cancer: new cancer treatment successes identified in phase 3 randomized controlled trials conducted by the National Cancer Institute-sponsored cooperative oncology groups, 1955 to 2006.
|
|
Academic Article
|
Accelerated approval of cancer drugs: improved access to therapeutic breakthroughs or early release of unsafe and ineffective drugs?
|
|
Academic Article
|
Economic analysis of a randomized placebo-controlled phase III study of granulocyte macrophage colony stimulating factor in adult patients (> 55 to 70 years of age) with acute myelogenous leukemia. Eastern Cooperative Oncology Group (E1490).
|
|
Academic Article
|
An evidence-based analysis of the effect of busulfan, hydroxyurea, interferon, and allogeneic bone marrow transplantation in treating the chronic phase of chronic myeloid leukemia: developed for the American Society of Hematology.
|
|
Academic Article
|
Valuing clinical strategies early in development: a cost analysis of allogeneic peripheral blood stem cell transplantation.
|
|
Academic Article
|
Single-therapy androgen suppression in men with advanced prostate cancer: a systematic review and meta-analysis.
|
|
Academic Article
|
Economic analysis of amifostine as adjunctive support for patients with advanced head and neck cancer: preliminary results from a randomized phase II clinical trial from Germany.
|
|
Academic Article
|
Clinical trials: are they a good buy?
|